Related references
Note: Only part of the references are listed.Effect of Linezolid Compared With Glycopeptides in Methicillin-Resistant Staphylococcus aureus Severe Pneumonia in Piglets
Carlos M. Luna et al.
CHEST (2009)
Early Microbiological Response to Linezolid vs Vancomycin in Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Richard G. Wunderink et al.
CHEST (2008)
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2008)
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid
Sungmin Kiem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
S. Kohno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia
MH Scheetz et al.
PHARMACOTHERAPY (2006)
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer
B Jaksic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia
E Boselli et al.
CRITICAL CARE MEDICINE (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study
JA Cepeda et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
M Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
JH Powers et al.
CHEST (2004)
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia
AC Kalil et al.
CHEST (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Intrapulmonary penetration of linezolid
D Honeybourne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
RG Wunderink et al.
CLINICAL THERAPEUTICS (2003)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Intrapulmonary pharmacokinetics of linezolid
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
E Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2001)
Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)